Search alternatives:
patient decrease » point decrease (Expand Search), transient decrease (Expand Search), largest decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ patient » _ patients (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
patient decrease » point decrease (Expand Search), transient decrease (Expand Search), largest decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ patient » _ patients (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
-
1
-
2
-
3
-
4
Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.
Published 2025“…<p>Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.</p>…”
-
5
-
6
-
7
-
8
-
9
Baseline patient characteristics.
Published 2025“…We evaluated these effects in a randomized controlled pilot trial. This study was conducted as part of a randomized controlled trial originally designed to assess the effects of s-ketamine conditioning on pain sensitivity in patients with fibromyalgia syndrome. …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Baseline patient characteristics across neutralizing monoclonal antibody trials.
Published 2025Subjects: -
19
Knock-down of DYRK1A decreases HBV RNAs levels in HBV-infected dHepaRG cells.
Published 2024Subjects: -
20